Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Data-Driven Structure-Property Analysis and Rational-Efficient Retrosynthetic Design of 1,2-Dihydronaphtho[2,1‑<i>b</i>]furan Derivatives via Interpretable Machine Learning.

ACS omega·2026
Same author

Catalyst-Free Upcycling of Polyethylene Waste Into Oxidized Polyethylene Wax.

Angewandte Chemie (International ed. in English)·2026
Same author

Bromination of Cannabinoids from <i>Cannabis sativa</i> L.: A Comparative Study Using an Enzymatic Catalysis Approach.

Organic letters·2026
Same author

Machine Learning-Driven QSAR Modeling for pK<sub>a</sub> Prediction of Ionizable Lipids in Lipid Nanoparticles for Hepatic Gene Silencing.

International journal of molecular sciences·2026
Same author

Integrating QSAR-Machine Learning, Biochemical Assays, and Molecular Dynamics for the Discovery of JAK2 Inhibitors in Cervical Cancer.

Journal of chemical information and modeling·2026
Same author

Molecular Dynamics and Solvated Interaction Energy Prioritize Cannabidiol and Cannabinol as Variant-Spanning SARS-CoV-2 RBD-ACE2 Interface Blockers.

Molecules (Basel, Switzerland)·2026

Related Experiment Video

Updated: Sep 19, 2025

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.1K

Machine Learning-Driven QSAR Modeling of Anticancer Activity from a Rationally Designed Synthetic Flavone Library.

Natthanan Vijara1, Borwornlak Toopradab2,3, Jantana Yahuafai4

  • 1Center of Excellence in Natural Products Chemistry, Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok, 10330, Thailand.

Chemmedchem
|May 30, 2025
PubMed
Summary

This study developed a machine learning quantitative structure-activity relationship (QSAR) model to design potent anticancer flavone derivatives. The model identified promising drug candidates with enhanced cytotoxicity against breast and liver cancer cells.

Keywords:
anticancer activitydrug discoveryflavonesmachine learningquantitative structure–activity relationship

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.5K
Chick Heart Invasion Assay for Testing the Invasiveness of Cancer Cells and the Activity of Potentially Anti-invasive Compounds
10:16

Chick Heart Invasion Assay for Testing the Invasiveness of Cancer Cells and the Activity of Potentially Anti-invasive Compounds

Published on: June 6, 2015

9.2K

Related Experiment Videos

Last Updated: Sep 19, 2025

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.1K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.5K
Chick Heart Invasion Assay for Testing the Invasiveness of Cancer Cells and the Activity of Potentially Anti-invasive Compounds
10:16

Chick Heart Invasion Assay for Testing the Invasiveness of Cancer Cells and the Activity of Potentially Anti-invasive Compounds

Published on: June 6, 2015

9.2K

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Drug Discovery

Background:

  • Flavones are recognized as privileged scaffolds in drug discovery, showing significant promise as anticancer agents.
  • Optimizing lead compounds for anticancer drug development requires efficient methodologies.
  • Quantitative structure-activity relationship (QSAR) models can accelerate the identification of potent drug candidates.

Purpose of the Study:

  • To develop and validate a machine learning-driven QSAR model for anticancer flavone derivatives.
  • To design and synthesize novel flavone analogs with enhanced cytotoxicity against cancer cell lines.
  • To identify key molecular descriptors that influence the anticancer activity of flavones.

Main Methods:

  • Design and synthesis of 89 flavone analogs using pharmacophore modeling.
  • Biological evaluation of synthesized compounds against breast (MCF-7) and liver (HepG2) cancer cell lines, and normal Vero cells.
  • Development and comparison of machine learning models (Random Forest, Extreme Gradient Boosting, Artificial Neural Network) for QSAR analysis.
  • Validation of the best-performing model using test compounds and SHapley Additive exPlanations (SHAP) for descriptor analysis.

Main Results:

  • Promising flavone candidates exhibited enhanced cytotoxicity against MCF-7 and HepG2 cancer cells with low toxicity to normal cells.
  • The Random Forest (RF) model demonstrated superior performance, achieving R² values of 0.820 (MCF-7) and 0.835 (HepG2).
  • Cross-validation (R²cv) and test set validation confirmed the robustness of the QSAR model, with RMSEtest values of 0.573 (MCF-7) and 0.563 (HepG2).
  • SHAP analysis identified critical molecular descriptors influencing anticancer activity, aiding in rational drug design.

Conclusions:

  • A robust machine learning-driven QSAR model was successfully developed for anticancer flavone derivatives.
  • The model facilitates the rational design of selective and potent anticancer agents.
  • This approach accelerates the optimization of lead compounds in anticancer drug discovery.